Ischemic heart disease — all decisions

The Board denied service connection for a heart disorder, including coronary artery disease and CABG, as the evidence did not show that these conditions were related to the Veteran's military service or exposure to contaminated water at Camp Lejeune.

The Board denied service connection for emphysema, prostate cancer, and coronary artery disease as the evidence did not support a causal relationship between these conditions and the Veteran's active duty or asbestos exposure.

The Board denied the Veteran's claim for service connection for ischemic heart disease (IHD), diagnosed as coronary artery disease (CAD), finding that there was no evidence of in-service exposure to herbicide agents and that his IHD was not related to his military service.

The Board dismissed the claims for earlier effective dates and higher ratings for various conditions, including left eye condition, right eye condition, hypertension, left knee, right knee, obstructive sleep apnea, and coronary artery disease (CAD), as well as denied an earlier effective date for CAD.

The Board remands the claims for service connection and TDIU due to a pre-decisional duty to assist error regarding SSA records.

The Board remands the claims for service connection for chronic kidney disease, hypertension, supraventricular arrhythmias, erectile dysfunction and coronary artery disease to correct a pre-decisional duty to assist error.

The Board granted a 60 percent disability rating for valvular heart disease with sinus bradycardia, but denied a higher rating and TDIU for PTSD.

The Board denied an initial evaluation in excess of 50 percent for PTSD, granted a 30 percent evaluation for right eye vision impairment, and denied an initial evaluation in excess of 60 percent for CAD. The Board remanded claims for service connection for obstructive sleep apnea and entitlement to a higher level of special monthly compensation.

The appeal was denied for an earlier effective date and increased rating for the service-connected conditions, but granted SMC based on need for aid and attendance.

The Board granted service connection for lumbar spine degenerative disc disease and coronary artery disease associated with herbicide agent exposure. Bilateral hearing loss was denied.

The appeal was denied due to the untimeliness of the higher-level review request and the failure to meet criteria for earlier effective dates and increased ratings for various service-connected conditions.

The Board granted service connection for heart disease, diagnosed as valvular and hypertensive heart disease, as secondary to the Veteran's service-connected hypertension. The claims for myasthenia gravis and an initial compensable rating for hypertension were remanded.

The Board granted service connection for diabetes mellitus, coronary artery disease, and hypertension based on the Veteran's exposure to herbicide agents while stationed in Guam.

The appeal for an earlier effective date prior to June 6, 2019, for coronary artery disease (CAD) was dismissed due to improper docketing of the appeal.

The appeal seeking revision on the basis of clear and unmistakable error (CUE) of the October 2015 rating decision that assigned an effective date of June 24, 2015, for the award of service connection for diabetes mellitus type II was denied. The October 2015 rating decision was revised to reflect an earlier effective date of June 24, 2014, for the award of service connection for coronary artery disease (CAD).

The Board granted service connection for COPD and denied an initial rating in excess of 30 percent for arteriosclerotic heart disease with myocardial infarction.

The Board granted readjudication of entitlement to service connection for ischemic heart disease (IHD) and remanded the claims for service connection for a heart condition and obstructive sleep apnea.

The Board denied service connection for multiple conditions, including radical cystectomy residuals with colonic pouch, ventral hernia, hypertension, and others, as the evidence did not corroborate the Veteran's reported exposure to Agent Orange or asbestos during service.

The Board granted earlier effective dates for the grant of service connection for chronic kidney disease, coronary artery disease, and diabetes mellitus, type II, from September 28, 2021. The claim for COPD was denied as no new and relevant evidence has been received.

The Board remands the claims for service connection for obstructive sleep apnea and acute, subacute, or old myocardial infarction, with arteriosclerotic heart disease (coronary artery disease), valvular heart disease, heart block, coronary artery bypass graft, cardiomyopathy, and mild cardiomegaly to obtain additional medical evidence.